FDA Approves Vertex's Non-Opioid Painkiller Journavx

Boston, Friday, 31 January 2025.
Vertex’s approval for Journavx marks a significant breakthrough in non-opioid pain management, offering a safer alternative for acute pain in adults, amid growing concerns over opioid addiction.